Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Cash from Operations (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Cash from Operations readings, the most recent being 390139.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 9.16% to 390139.0 in Q1 2026 year-over-year; TTM through Jan 2026 was 175539.0, a 89.81% increase, with the full-year FY2025 number at 214886.0, up 62.08% from a year prior.
  • Cash from Operations hit 390139.0 in Q1 2026 for Pharma-Bio Serv, down from 279666.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 1105853.0 in Q3 2022 to a low of 700744.0 in Q2 2024.
  • Median Cash from Operations over the past 5 years was 78425.0 (2024), compared with a mean of 77158.29.
  • Biggest five-year swings in Cash from Operations: soared 367.68% in 2023 and later tumbled 180.18% in 2024.
  • Pharma-Bio Serv's Cash from Operations stood at 260091.0 in 2022, then rose by 18.59% to 308436.0 in 2023, then crashed by 74.57% to 78425.0 in 2024, then soared by 256.6% to 279666.0 in 2025, then tumbled by 239.5% to 390139.0 in 2026.
  • The last three reported values for Cash from Operations were 390139.0 (Q1 2026), 279666.0 (Q4 2025), and 236524.0 (Q3 2025) per Business Quant data.